Fairfield Clinical Site 110 — Fairfield, Connecticut

Fairfield Clinical Site 110 is a clinical research site located in Fairfield, Connecticut, United States 06824.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Fairfield Clinical Site 110 has participated in 2 clinical trials.

Therapeutic areas: Multiple Sclerosis.

Sponsors: Ono Pharma USA Inc, EMD Serono.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Fairfield

Browse all research sites in Connecticut · View every site in Fairfield

• The Carolton Chronic and Convalescent Hospital
• Fairfield University
• Yale University School Of Medicine
• Sacred Heart University
• Smilow Cancer Hospital Care Center at Fairfield
• Smilow Cancer Hospital Care Center
• Yale University
• Smilow Cancer Hospital Care Center-Fairfield
• Smilow Cancer Hospital at Fairfield
• Smilow Cancer Hospital - Fairfield
• Research Site
• Associated Neurologists of Southern CT, P.C.

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Fairfield Clinical Site 110?

Fairfield Clinical Site 110 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Fairfield Clinical Site 110 conducted?

Fairfield Clinical Site 110 has 2 clinical trials on record. Their work covers Multiple Sclerosis.

Is Fairfield Clinical Site 110 accredited by Crixeo Clinical Trials?

Fairfield Clinical Site 110 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Fairfield Clinical Site 110?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.